Boston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE